NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,962,657 | $3,100,000 | 2.37% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $62,000 | 0.02% |
| SlateStone Wealth, LLC | 62,000 | $39,000 | 0.01% |
| Allred Capital Management, LLC | 24,995 | $15,000 | 0.01% |
| Bridge Advisory, LLC | 23,564 | $15,000 | 0.01% |
| Livingston Group Asset Management CO (operating as Southport Capital Management) | 24,000 | $15,000 | 0.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 320,993 | $201,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 229,500 | $143,000 | 0.00% |
| Virtu Financial LLC | 41,401 | $26,000 | 0.00% |
| TSFG, LLC | 200 | $1,000 | 0.00% |